Concepedia

Douglas Vernimmen

DV

23

Publications

2.5K

Citations

18

H-Index

1999

Active since

Affiliations

University of Edinburgh(Current)

University of Oxford

John Radcliffe Hospital

Roslin Institute

MRC Weatherall Institute of Molecular Medicine

Douglas Vernimmen is an author at University of Edinburgh specializing in medicine, gene expression, and natural sciences.

ORCID

Top concepts

Publications per year

1999–2021

23

Publications

23

Targeting the RNA m6A Reader YTHDF2 Selectively Compromises Cancer Stem Cells in Acute Myeloid Leukemia

J Paris, Marcos Morgan, Joana Campos et al. · Cell stem cell · 2019 · 542 citations · Full text

A Regulatory SNP Causes a Human Genetic Disease by Creating a New Transcriptional Promoter

Marco De Gobbi, Vip Viprakasit, Jim R. Hughes et al. · Science · 2006 · 282 citations

Intragenic Enhancers Act as Alternative Promoters

Monika S. Kowalczyk, Jim R. Hughes, David Garrick et al. · Molecular Cell · 2012 · 266 citations · Full text

, , +4

Long‐range chromosomal interactions regulate the timing of the transition between poised and active gene expression

Douglas Vernimmen, Marco De Gobbi, Jacqueline A. Sloane-Stanley et al. · The EMBO Journal · 2007 · 239 citations · Full text

An interspecies analysis reveals a key role for unmethylated CpG dinucleotides in vertebrate Polycomb complex recruitment

Magnus Lynch, Andrew J. H. Smith, Marco De Gobbi et al. · The EMBO Journal · 2011 · 196 citations · Full text

, , +11

Rows per page

1–5 of 23